News archives

Home > News archives > Closing of the funding to accelerate R&D

Closing of the funding to accelerate R&D

Nov 2,2016 -- Updated 22:48 +0900 (GMT)

Sapporo, Japan, Oct. 28, 2016 – NB Health Laboratory Co. Ltd. (Head Office: Kita-Ku, Sapporo; President: Kiyoshi Takayama, Ph.D.) today announced that NBHL has raised ¥200 million in an equity funding round through Fast Track Initiative Fund II, L.P.
managed by Fast Track Initiative, Inc. (Head Office: Bunkyo-Ku Tokyo; CEO Hiromichi Kimura, PhD). The funds will be used to accelerate development of NBHL original bio medicine.